AbsEn.i
Exploration
Accueil
Racine
Exploration
Accueil

Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « AbsEn.i » - entrée « search »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
seafood < search < searched  Facettes :

List of bibliographic references indexed by search

Number of relevant bibliographic references: 69.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000037 (2021) Isabel Fambuena-Muedra [Espagne] ; Marta Jiménez-García [Belgique] ; Sarah Hershko [Belgique] ; Irene Altemir-G Mez [Espagne] ; Ana Tobarra-L Pez [Espagne]What can visual caregivers expect with patients treated for SARS-CoV-2? An analysis of ongoing clinical trials and ocular side effects.
000065 (2021) Guobing Li [République populaire de Chine, États-Unis] ; Shasha Ruan [République populaire de Chine] ; Xiaolu Zhao [République populaire de Chine] ; Qi Liu [États-Unis] ; Yali Dou [États-Unis] ; Fengbiao Mao [République populaire de Chine]Transcriptomic signatures and repurposing drugs for COVID-19 patients: findings of bioinformatics analyses.
000084 (2021) Bhanu Prasad Venkatesulu [États-Unis] ; Viveksandeep Thoguluva Chandrasekar [États-Unis] ; Prashanth Giridhar [Inde] ; Pragathee V [Inde] ; Harsh K. Patel [États-Unis] ; Jacob Manteuffel [États-Unis]The mechanistic rationale of drugs, primary endpoints, geographical distribution of clinical trials against severe acute respiratory syndrome-related coronavirus-2: A systematic review.
000129 (2021) Sinosh Skariyachan [Inde] ; Dharshini Gopal [Inde] ; Aditi G. Muddebihalkar [Inde] ; Akshay Uttarkar [Inde] ; Vidya Niranjan [Inde]Structural insights on the interaction potential of natural leads against major protein targets of SARS-CoV-2: Molecular modelling, docking and dynamic simulation studies.
000181 (2021) Pravindra Kumar [Inde] ; Ashok Kumar Sah [Inde] ; Greesham Tripathi [Inde] ; Anjali Kashyap [Inde] ; Avantika Tripathi [Inde] ; Rashmi Rao [Inde] ; Prabhu C. Mishra [Inde] ; Koustav Mallick [Inde] ; Amjad Husain [Inde] ; Manoj Kumar Kashyap [Inde]Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19.
000188 (2021) Veronique Michaud [États-Unis, Canada] ; Pamela Dow [États-Unis] ; Sweilem B. Al Rihani [États-Unis] ; Malavika Deodhar [États-Unis] ; Meghan Arwood [États-Unis] ; Brian Cicali [États-Unis] ; Jacques Turgeon [États-Unis, Canada]Risk Assessment of Drug-Induced Long QT Syndrome for Some COVID-19 Repurposed Drugs.
000191 (2021) Dhruva Sharma [Inde] ; Neha Sharma [Inde] ; Preksha Sharma [Inde] ; Ganapathy Subramaniam [Inde]Review of investigational drugs for coronavirus disease 2019.
000269 (2021) Miguel Angel Martinez [Espagne]Plitidepsin: a Repurposed Drug for the Treatment of COVID-19.
000311 (2021) Aitebiremen Gift Omokhua-Uyi [Afrique du Sud] ; Johannes Van Staden [Afrique du Sud]Natural product remedies for COVID-19: A focus on safety.
000339 (2021) Ritwick Mondal [Inde] ; Upasana Ganguly [Inde] ; Shramana Deb [Inde] ; Gourav Shome [Inde] ; Subhasish Pramanik [Inde] ; Deebya Bandyopadhyay [Inde] ; Durjoy Lahiri [Inde]Meningoencephalitis associated with COVID-19: a systematic review.
000378 (2021) Melanie M. Taylor [États-Unis] ; Loulou Kobeissi [Suisse] ; Caron Kim [Suisse] ; Avni Amin [Suisse] ; Anna E. Thorson [Suisse] ; Nita B. Bellare [Suisse] ; Vanessa Brizuela [Suisse] ; Mercedes Bonet [Suisse] ; Edna Kara [Suisse] ; Soe Soe Thwin [Suisse] ; Hamsadvani Kuganantham [Suisse] ; Moazzam Ali [Suisse] ; Olufemi T. Oladapo [Suisse] ; Nathalie Broutet [Suisse]Inclusion of pregnant women in COVID-19 treatment trials: a review and global call to action.
000437 (2021) Hozaifa Khalil Elsawah [Égypte] ; Mohamed Ahmed Elsokary [Égypte] ; Mahmoud Gamal Elrazzaz [Égypte] ; Ahmed Hanei Elshafie [Égypte]Hydroxychloroquine for treatment of nonsevere COVID-19 patients: Systematic review and meta-analysis of controlled clinical trials.
000501 (2021) Michael Putman [États-Unis] ; Sebastian E. Sattui [États-Unis] ; Jeffrey A. Sparks [États-Unis] ; Jean W. Liew [États-Unis] ; Rebecca Grainger [Nouvelle-Zélande] ; Alí Duarte-García [États-Unis]Evidence in the Time of COVID-19.
000551 (2021) Muhammad Taher [Malaisie] ; Noratika Tik [Malaisie] ; Deny Susanti [Malaisie]Drugs intervention study in COVID-19 management.
000609 (2021) Jagdish Prasad Meena [Inde] ; Aditya Kumar Gupta [Inde] ; Pranay Tanwar [Inde] ; Kana Ram Jat [Inde] ; Ravindra Mohan Pandey [Inde] ; Rachna Seth [Inde]Clinical presentations and outcomes of children with cancer and COVID-19: A systematic review.
000633 (2021) Bhagteshwar Singh [Royaume-Uni, Inde] ; Hannah Ryan [Royaume-Uni] ; Tamara Kredo [Afrique du Sud] ; Marty Chaplin [Royaume-Uni] ; Tom Fletcher [Royaume-Uni]Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.
000643 (2021) Tzu-Chuan Ho [Taïwan] ; Yung-Hsuan Wang [Taïwan] ; Yi-Ling Chen [Taïwan] ; Wan-Chi Tsai [Taïwan] ; Che-Hsin Lee [Taïwan] ; Kuo-Pin Chuang [Taïwan] ; Yi-Ming Arthur Chen [Taïwan] ; Cheng-Hui Yuan [Singapour] ; Sheng-Yow Ho [Taïwan] ; Ming-Hui Yang [Taïwan] ; Yu-Chang Tyan [Taïwan]Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19.
000673 (2021) Onion Gerald V. Ubaldo [Philippines] ; Jose Emmanuel M. Palo [Philippines] ; Jude Erric L. Cinco [Philippines]COVID-19: A Single-Center ICU Experience of the First Wave in the Philippines.
000768 (2021) Maheswara Rao Gokada ; Visweswara Rao Pasupuleti ; Hari Babu BollikollaA mini review on emerging targets and Approaches for the synthesis of Anti-Viral compounds: In perspective to COVID-19.
000796 (2021) Roberto Barbosa Bazotte [Brésil] ; Sandro Massao Hirabara [Brésil] ; Tamires Afonso Duarte Serdan [Brésil] ; Raquel Bragante Gritte [Brésil] ; Talita Souza-Siqueira [Brésil] ; Renata Gorjao [Brésil] ; Laureane Nunes Masi [Brésil] ; Marina Masetto Antunes [Brésil] ; Vinicius Cruzat [Australie] ; Tania Cristina Pithon-Curi [Brésil] ; Rui Curi [Brésil]4-Aminoquinoline compounds from the Spanish flu to COVID-19.
000849 (2020) Awadhesh Kumar Singh [Inde] ; Akriti Singh [Inde] ; Altamash Shaikh [Inde] ; Ritu Singh [Inde] ; Anoop Misra [Inde]Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "search" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "search" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    search
}}
Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021